These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 16118230)

  • 1. Arthritis and inflammatory eye disease.
    Bucknall RC
    Rheumatology (Oxford); 2005 Oct; 44(10):1207-9. PubMed ID: 16118230
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of tumor necrosis factor inhibitors in uveitis.
    Rabinovich CE
    Curr Opin Rheumatol; 2007 Sep; 19(5):482-6. PubMed ID: 17762615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebral MRI is necessary in patients with rheumatoid arthritis and uveitis before undergoing therapy with TNF-alpha blocking agents.
    Limmroth V; Thimm C; Hudde T; Fuchsluger T; Wanke I
    Rheumatology (Oxford); 2005 Nov; 44(11):1373. PubMed ID: 16244102
    [No Abstract]   [Full Text] [Related]  

  • 4. [Inhibitors of tumour necrosis factor-alpha for the treatment of arthritis and uveitis in childhood].
    Heiligenhaus A; Horneff G; Greiner K; Mackensen F; Zierhut M; Foeldvari I; Michels H
    Klin Monbl Augenheilkd; 2007 Jun; 224(6):526-31. PubMed ID: 17594625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The role of tumor necrosis factor in inflammation].
    Muşat O
    Oftalmologia; 2005; 49(2):23-6. PubMed ID: 16245739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-TNF-alpha therapy in patients with chronic non-infectious uveitis: the experience of Jules Gonin Eye Hospital.
    Petropoulos IK; Vaudaux JD; Guex-Crosier Y
    Klin Monbl Augenheilkd; 2008 May; 225(5):457-61. PubMed ID: 18454398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infliximab: a novel treatment for sight-threatening thyroid associated ophthalmopathy.
    Durrani OM; Reuser TQ; Murray PI
    Orbit; 2005 Jun; 24(2):117-9. PubMed ID: 16191800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of ocular cicatricial pemphigoid with the tumour necrosis factor alpha antagonist etanercept.
    Prey S; Robert PY; Drouet M; Sparsa A; Roux C; Bonnetblanc JM; Bédane C
    Acta Derm Venereol; 2007; 87(1):74-5. PubMed ID: 17225020
    [No Abstract]   [Full Text] [Related]  

  • 9. Seronegative spondyloarthropathies and the eye.
    Ali A; Samson CM
    Curr Opin Ophthalmol; 2007 Nov; 18(6):476-80. PubMed ID: 18162999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Eye involvement in colagenoses].
    Meythaler H
    Med Welt; 1970 May; 22():1018-20. PubMed ID: 5509751
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-term efficacy of infliximab treatment for AA-amyloidosis secondary to chronic inflammatory arthritis.
    Keersmaekers T; Claes K; Kuypers DR; de Vlam K; Verschueren P; Westhovens R
    Ann Rheum Dis; 2009 May; 68(5):759-61. PubMed ID: 19366896
    [No Abstract]   [Full Text] [Related]  

  • 12. Retinal vasculitis associated with anterior uveitis.
    Nolan J; Cullen JF
    Br J Ophthalmol; 1967 Jun; 51(6):361-4. PubMed ID: 6027626
    [No Abstract]   [Full Text] [Related]  

  • 13. [Recommendations for the diagnosis and treatment of latent and active tuberculosis in patients with inflammatory joint diseases treated with tumour necrosis factor alpha inhibitors].
    Fonseca JE; Lucas H; Canhão H; Duarte R; Santos MJ; Villar M; Faustino A; Raymundo E; ;
    Acta Reumatol Port; 2006; 31(3):237-45. PubMed ID: 17094335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ["TRECID", TNFalpha related chronic inflammatory diseases - a new multiple diseases bridging concept].
    Müller-Ladner U; Alten R; Heiligenhaus A; Kekow J; Koletzko S; Mrowietz U; Ochsenkühn T; Radke M; Reich K; Rudwaleit M; Schreiber S
    Dtsch Med Wochenschr; 2009 Oct; 134(42):2132-6. PubMed ID: 19809965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Guidelines for the diagnosis and treatment of latent tuberculosis infection and active tuberculosis in patients with inflammatory joint diseases proposed for treatment with tumour necrosis factor alpha antagonist drugs].
    Fonseca JE; Lucas H; Canhão H; Duarte R; Santos MJ; Villar M; Faustino A; Raymundo E; ;
    Rev Port Pneumol; 2006; 12(5):603-13. PubMed ID: 17117328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sarcoidosis, role of tumor necrosis factor inhibitors and other biologic agents, past, present, and future concepts.
    Sweiss NJ; Curran J; Baughman RP
    Clin Dermatol; 2007; 25(3):341-6. PubMed ID: 17560312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular mechanisms of topical anti-inflammatory effects of lipoxin A(4) in endotoxin-induced uveitis.
    Medeiros R; Rodrigues GB; Figueiredo CP; Rodrigues EB; Grumman A; Menezes-de-Lima O; Passos GF; Calixto JB
    Mol Pharmacol; 2008 Jul; 74(1):154-61. PubMed ID: 18413658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumour necrosis factor alpha inhibitors in the treatment of childhood uveitis.
    Saurenmann RK; Levin AV; Rose JB; Parker S; Rabinovitch T; Tyrrell PN; Feldman BM; Laxer RM; Schneider R; Silverman ED
    Rheumatology (Oxford); 2006 Aug; 45(8):982-9. PubMed ID: 16461435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biologics in the treatment of uveitis.
    Imrie FR; Dick AD
    Curr Opin Ophthalmol; 2007 Nov; 18(6):481-6. PubMed ID: 18163000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TNFalpha-blocking agents or conventional immunosuppressive drugs in the therapy of children with uveitis? - an evidence based approach.
    Winterhalter S; Niehues T
    Klin Padiatr; 2008; 220(6):342-7. PubMed ID: 18949668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.